Peer-reviewed article

Lumateperone (Caplyta) for adjunctive treatment of depression.

The Medical letter on drugs and therapeuticsFeb 1, 20260 citationsDOI: 10.58347/tml.2026.1747c

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Keywords

PregnancySafetyLactationAdverse effectsDosagefluoxetineDrug interactionsolanzapineefficacylithiumAntipsychoticsAripiprazoleZyprexaquetiapineSeroquel

View paper

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticleKetamine

Pharmacologic Approaches to Suicide Prevention.

Zisook S, Domingues I, Compton J

Europe PMC2023

ArticleKetamine

Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature.

Drozdz SJ, Goel A, McGarr MW +6

Europe PMC2022

ArticleKetamine

Effects of ketamine on individual symptoms and symptom networks of depression in a randomised controlled trial of ketamine for treatment-resistant depression.

Hossein S, Rengasamy M, Uzamere A +5

Europe PMC2025